RXRX Form 144: Blake Borgeson Sells 220K Shares

RXRX Form 144 notice reports two block sales of Class A shares by Blake Borgeson.

Rhea-AI Filing Summary

RXRX Form 144 notice reports two block sales of Class A shares by Blake Borgeson. The filing lists a sale on 01/06/2026 of 220,000 Class A shares for $959,200 and a sale on 02/03/2026 of 220,000 Class A shares for $924,000.

The filing also lists earlier issuer-designated Class A founder/compensation share entries dated 09/01/2016 (110,000) and 09/01/2017 (60,000).

Insights

Insider Transactions Compliance Analyst

Form 144 discloses two dated block dispositions by a single holder, with transaction amounts and gross proceeds stated.

The filing lists a 220,000-share sale on 01/06/2026 for $959,200 and a second 220,000-share sale on 02/03/2026 for $924,000. These entries identify the seller and broker details.

Compliance depends on Rule 144 conditions such as holding periods and public information; subsequent filings may show clearing or settlement details or broker confirmations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did RXRX report on the Form 144?

The filing reports two Class A share dispositions by Blake Borgeson: 220,000 shares sold on 01/06/2026 for $959,200 and 220,000 shares sold on 02/03/2026 for $924,000. It lists broker and grant dates.

Who is the seller named in the RXRX Form 144?

The seller is identified as Blake Borgeson with a Salt Lake City address. The filing lists two separate Class A share dispositions bearing specific dates and gross proceeds for each transaction.

How many shares and proceeds are shown in each RXRX transaction?

Each reported transaction shows 220,000 Class A shares. The first on 01/06/2026 shows $959,200 and the second on 02/03/2026 shows $924,000 as the gross amounts reported.

Does the Form 144 list any issuer share grants or reserves for RXRX?

Yes, the excerpt lists issuer-designated Class A entries: 110,000 shares dated 09/01/2016 and 60,000 shares dated 09/01/2017, described as founders/compensation in the securities table.

Does the Form 144 state whether proceeds were received by the issuer?

The excerpt does not state proceeds treatment. The filing shows gross amounts for the seller transactions but does not explicitly allocate proceeds to the issuer or selling holder in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 12:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001856094
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RECURSION PHARMACEUTICALS, INC.
SEC File Number	001-40323
Address of Issuer	41S RIO GRANDE STREET SALT LAKE CITY UTAH 84101
Phone	(385) 269-0203
Name of Person for Whose Account the Securities are To Be Sold	Borgeson Blake
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	170000	588200.00	521950663	03/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/01/2016	Founders Shares	Issuer			110000	09/01/2016	Compensation
Class A	09/01/2017	Founders Shares	Issuer			60000	09/01/2017	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Blake Borgeson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	01/06/2026	220000	959200.00
Blake Borgeson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	02/03/2026	220000	924000.00

144: Remarks and Signature

Remarks
Date of Notice	03/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/31/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Blake Borgeson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)